This company listing is no longer active
Aceragen Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 2/6
Aceragen has a total shareholder equity of $57.3M and total debt of $733.0K, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are $78.5M and $21.1M respectively.
Wichtige Informationen
1.3%
Verhältnis von Schulden zu Eigenkapital
US$733.00k
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | US$2.12m |
| Eigenkapital | US$57.35m |
| Gesamtverbindlichkeiten | US$21.14m |
| Gesamtvermögen | US$78.49m |
Jüngste Berichte zur Finanzlage
We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Aug 24
We Think Idera Pharmaceuticals (NASDAQ:IDRA) Needs To Drive Business Growth Carefully
May 11Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans?
Mar 07Recent updates
Idera Pharmaceuticals completes acquisition of Aceragen
Sep 28We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Aug 24We Think Idera Pharmaceuticals (NASDAQ:IDRA) Needs To Drive Business Growth Carefully
May 11Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans?
Mar 07When Will Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Become Profitable?
Jan 31Idera outlines capital requirement to move tilsotolimod toward commercialization in advanced melanoma
Jan 13Could The Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Ownership Structure Tell Us Something Useful?
Dec 27Don't Ignore The Fact That This Insider Just Sold Some Shares In Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Dec 27Idera Pharmaceuticals receives $5M in additional proceeds from private placement
Dec 15We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Nov 25Idera Pharma names new operations chief
Nov 17Idera Pharmaceuticals EPS misses by $0.37
Oct 29Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: ACGN's short term assets ($5.6M) do not cover its short term liabilities ($17.9M).
Langfristige Verbindlichkeiten: ACGN's short term assets ($5.6M) exceed its long term liabilities ($3.3M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: ACGN has more cash than its total debt.
Schulden abbauen: ACGN's debt to equity ratio has increased from 0.1% to 1.3% over the past 5 years.
Bilanz
Liquiditätsreserve-Analyse
Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.
Stabile Start- und Landebahn für Bargeld: ACGN has less than a year of cash runway based on its current free cash flow.
Vorhersage Cash Runway: ACGN has less than a year of cash runway if free cash flow continues to grow at historical rates of 13.3% each year.